Industry Research Reports

Home > Reports > Pharma & Healthcare > Basal Insulin (Long-Acting Insulin) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Basal Insulin (Long-Acting Insulin) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 101 Pages

Report ld: 2622709

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Long-acting insulins are also called basal or background insulins. The role of basal insulin, also known as background insulin, is to keep blood glucose levels at consistent levels during periods of fasting. When fasting , the body steadily releases glucose into the blood to our cells supplied with energy.

The global market for Basal Insulin (Long-Acting Insulin) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Basal Insulin (Long-Acting Insulin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Basal Insulin (Long-Acting Insulin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Basal Insulin (Long-Acting Insulin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Basal Insulin (Long-Acting Insulin) include Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico and Wockhardt, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Basal Insulin (Long-Acting Insulin), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Basal Insulin (Long-Acting Insulin) by region & country, by Type, and by Application.

The Basal Insulin (Long-Acting Insulin) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Basal Insulin (Long-Acting Insulin).

Market Segmentation

Report Metric
Details
Report Title
Basal Insulin (Long-Acting Insulin) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Basal Insulin (Long-Acting Insulin) Companies Covered
Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico, Wockhardt
Global Basal Insulin (Long-Acting Insulin) Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Basal Insulin (Long-Acting Insulin) Market, Segment by Type
Lantus

Levemir

Tresiba

Toujeo

Basaglar

Biosimilar Glargines
Global Basal Insulin (Long-Acting Insulin) Market, Segment by Application
Type 1 Diabetes

Type 2 Diabetes
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Basal Insulin (Long-Acting Insulin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Basal Insulin (Long-Acting Insulin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Basal Insulin (Long-Acting Insulin) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Basal Insulin (Long-Acting Insulin) Product Introduction
    1.2 Global Basal Insulin (Long-Acting Insulin) Market Size Forecast
        1.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Value (2019-2030)
        1.2.2 Global Basal Insulin (Long-Acting Insulin) Sales Volume (2019-2030)
        1.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Price (2019-2030)
    1.3 Basal Insulin (Long-Acting Insulin) Market Trends & Drivers
        1.3.1 Basal Insulin (Long-Acting Insulin) Industry Trends
        1.3.2 Basal Insulin (Long-Acting Insulin) Market Drivers & Opportunity
        1.3.3 Basal Insulin (Long-Acting Insulin) Market Challenges
        1.3.4 Basal Insulin (Long-Acting Insulin) Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Basal Insulin (Long-Acting Insulin) Players Revenue Ranking (2023)
    2.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2019-2024)
    2.3 Global Basal Insulin (Long-Acting Insulin) Players Sales Volume Ranking (2023)
    2.4 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Company Players (2019-2024)
    2.5 Global Basal Insulin (Long-Acting Insulin) Average Price by Company (2019-2024)
    2.6 Key Manufacturers Basal Insulin (Long-Acting Insulin) Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Basal Insulin (Long-Acting Insulin) Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Basal Insulin (Long-Acting Insulin)
    2.9 Basal Insulin (Long-Acting Insulin) Market Competitive Analysis
        2.9.1 Basal Insulin (Long-Acting Insulin) Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Basal Insulin (Long-Acting Insulin) Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Lantus
        3.1.2 Levemir
        3.1.3 Tresiba
        3.1.4 Toujeo
        3.1.5 Basaglar
        3.1.6 Biosimilar Glargines
    3.2 Global Basal Insulin (Long-Acting Insulin) Sales Value by Type
        3.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Basal Insulin (Long-Acting Insulin) Sales Value, by Type (2019-2030)
        3.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Value, by Type (%) (2019-2030)
    3.3 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type
        3.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Basal Insulin (Long-Acting Insulin) Sales Volume, by Type (2019-2030)
        3.3.3 Global Basal Insulin (Long-Acting Insulin) Sales Volume, by Type (%) (2019-2030)
    3.4 Global Basal Insulin (Long-Acting Insulin) Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Type 1 Diabetes
        4.1.2 Type 2 Diabetes
    4.2 Global Basal Insulin (Long-Acting Insulin) Sales Value by Application
        4.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Basal Insulin (Long-Acting Insulin) Sales Value, by Application (2019-2030)
        4.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Value, by Application (%) (2019-2030)
    4.3 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application
        4.3.1 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Basal Insulin (Long-Acting Insulin) Sales Volume, by Application (2019-2030)
        4.3.3 Global Basal Insulin (Long-Acting Insulin) Sales Volume, by Application (%) (2019-2030)
    4.4 Global Basal Insulin (Long-Acting Insulin) Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Basal Insulin (Long-Acting Insulin) Sales Value by Region
        5.1.1 Global Basal Insulin (Long-Acting Insulin) Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (2019-2024)
        5.1.3 Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (2025-2030)
        5.1.4 Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (%), (2019-2030)
    5.2 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Region
        5.2.1 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Region (2019-2024)
        5.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Region (2025-2030)
        5.2.4 Global Basal Insulin (Long-Acting Insulin) Sales Volume by Region (%), (2019-2030)
    5.3 Global Basal Insulin (Long-Acting Insulin) Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        5.4.2 North America Basal Insulin (Long-Acting Insulin) Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        5.5.2 Europe Basal Insulin (Long-Acting Insulin) Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        5.6.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        5.7.2 South America Basal Insulin (Long-Acting Insulin) Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        5.8.2 Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Value
        6.2.1 Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        6.3.2 United States Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Basal Insulin (Long-Acting Insulin) Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        6.4.2 Europe Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Basal Insulin (Long-Acting Insulin) Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        6.5.2 China Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Basal Insulin (Long-Acting Insulin) Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        6.6.2 Japan Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Basal Insulin (Long-Acting Insulin) Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        6.7.2 South Korea Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Basal Insulin (Long-Acting Insulin) Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        6.8.2 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Basal Insulin (Long-Acting Insulin) Sales Value, 2019-2030
        6.9.2 India Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Basal Insulin (Long-Acting Insulin) Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Company Information
        7.1.2 Novo Nordisk Introduction and Business Overview
        7.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Offerings
        7.1.5 Novo Nordisk Recent Development
    7.2 Sanofi Aventis
        7.2.1 Sanofi Aventis Company Information
        7.2.2 Sanofi Aventis Introduction and Business Overview
        7.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Offerings
        7.2.5 Sanofi Aventis Recent Development
    7.3 Eli Lilly
        7.3.1 Eli Lilly Company Information
        7.3.2 Eli Lilly Introduction and Business Overview
        7.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Offerings
        7.3.5 Eli Lilly Recent Development
    7.4 Biocon
        7.4.1 Biocon Company Information
        7.4.2 Biocon Introduction and Business Overview
        7.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Biocon Basal Insulin (Long-Acting Insulin) Product Offerings
        7.4.5 Biocon Recent Development
    7.5 Julphar
        7.5.1 Julphar Company Information
        7.5.2 Julphar Introduction and Business Overview
        7.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Julphar Basal Insulin (Long-Acting Insulin) Product Offerings
        7.5.5 Julphar Recent Development
    7.6 Exir
        7.6.1 Exir Company Information
        7.6.2 Exir Introduction and Business Overview
        7.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Exir Basal Insulin (Long-Acting Insulin) Product Offerings
        7.6.5 Exir Recent Development
    7.7 Sedico
        7.7.1 Sedico Company Information
        7.7.2 Sedico Introduction and Business Overview
        7.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Sedico Basal Insulin (Long-Acting Insulin) Product Offerings
        7.7.5 Sedico Recent Development
    7.8 Wockhardt
        7.8.1 Wockhardt Company Information
        7.8.2 Wockhardt Introduction and Business Overview
        7.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Product Offerings
        7.8.5 Wockhardt Recent Development

 8 Industry Chain Analysis
    8.1 Basal Insulin (Long-Acting Insulin) Industrial Chain
    8.2 Basal Insulin (Long-Acting Insulin) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Basal Insulin (Long-Acting Insulin) Sales Model
        8.5.2 Sales Channel
        8.5.3 Basal Insulin (Long-Acting Insulin) Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Basal Insulin (Long-Acting Insulin) Market Trends
    Table 2. Basal Insulin (Long-Acting Insulin) Market Drivers & Opportunity
    Table 3. Basal Insulin (Long-Acting Insulin) Market Challenges
    Table 4. Basal Insulin (Long-Acting Insulin) Market Restraints
    Table 5. Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Company (2019-2024)
    Table 7. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Basal Insulin (Long-Acting Insulin) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Basal Insulin (Long-Acting Insulin) Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Basal Insulin (Long-Acting Insulin) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Basal Insulin (Long-Acting Insulin) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Basal Insulin (Long-Acting Insulin)
    Table 13. Global Basal Insulin (Long-Acting Insulin) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Basal Insulin (Long-Acting Insulin) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Basal Insulin (Long-Acting Insulin) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Basal Insulin (Long-Acting Insulin) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Basal Insulin (Long-Acting Insulin) Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Basal Insulin (Long-Acting Insulin) Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Basal Insulin (Long-Acting Insulin) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Basal Insulin (Long-Acting Insulin) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Basal Insulin (Long-Acting Insulin) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Basal Insulin (Long-Acting Insulin) Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Basal Insulin (Long-Acting Insulin) Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Basal Insulin (Long-Acting Insulin) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Basal Insulin (Long-Acting Insulin) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Basal Insulin (Long-Acting Insulin) Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Basal Insulin (Long-Acting Insulin) Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Volume, (2025-2030) & (K Units)
    Table 57. Novo Nordisk Company Information
    Table 58. Novo Nordisk Introduction and Business Overview
    Table 59. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Offerings
    Table 61. Novo Nordisk Recent Development
    Table 62. Sanofi Aventis Company Information
    Table 63. Sanofi Aventis Introduction and Business Overview
    Table 64. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Offerings
    Table 66. Sanofi Aventis Recent Development
    Table 67. Eli Lilly Company Information
    Table 68. Eli Lilly Introduction and Business Overview
    Table 69. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Eli Lilly Basal Insulin (Long-Acting Insulin) Product Offerings
    Table 71. Eli Lilly Recent Development
    Table 72. Biocon Company Information
    Table 73. Biocon Introduction and Business Overview
    Table 74. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Biocon Basal Insulin (Long-Acting Insulin) Product Offerings
    Table 76. Biocon Recent Development
    Table 77. Julphar Company Information
    Table 78. Julphar Introduction and Business Overview
    Table 79. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Julphar Basal Insulin (Long-Acting Insulin) Product Offerings
    Table 81. Julphar Recent Development
    Table 82. Exir Company Information
    Table 83. Exir Introduction and Business Overview
    Table 84. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Exir Basal Insulin (Long-Acting Insulin) Product Offerings
    Table 86. Exir Recent Development
    Table 87. Sedico Company Information
    Table 88. Sedico Introduction and Business Overview
    Table 89. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Sedico Basal Insulin (Long-Acting Insulin) Product Offerings
    Table 91. Sedico Recent Development
    Table 92. Wockhardt Company Information
    Table 93. Wockhardt Introduction and Business Overview
    Table 94. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Wockhardt Basal Insulin (Long-Acting Insulin) Product Offerings
    Table 96. Wockhardt Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Basal Insulin (Long-Acting Insulin) Downstream Customers
    Table 100. Basal Insulin (Long-Acting Insulin) Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Basal Insulin (Long-Acting Insulin) Product Picture
    Figure 2. Global Basal Insulin (Long-Acting Insulin) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Basal Insulin (Long-Acting Insulin) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Basal Insulin (Long-Acting Insulin) Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Basal Insulin (Long-Acting Insulin) Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Basal Insulin (Long-Acting Insulin) Report Years Considered
    Figure 7. Global Basal Insulin (Long-Acting Insulin) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Basal Insulin (Long-Acting Insulin) Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Basal Insulin (Long-Acting Insulin) Revenue in 2023
    Figure 10. Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Lantus Picture
    Figure 12. Levemir Picture
    Figure 13. Tresiba Picture
    Figure 14. Toujeo Picture
    Figure 15. Basaglar Picture
    Figure 16. Biosimilar Glargines Picture
    Figure 17. Global Basal Insulin (Long-Acting Insulin) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Basal Insulin (Long-Acting Insulin) Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 20. Global Basal Insulin (Long-Acting Insulin) Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Basal Insulin (Long-Acting Insulin) Price by Type (2019-2030) & (US$/Unit)
    Figure 22. Product Picture of Type 1 Diabetes
    Figure 23. Product Picture of Type 2 Diabetes
    Figure 24. Global Basal Insulin (Long-Acting Insulin) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Basal Insulin (Long-Acting Insulin) Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Basal Insulin (Long-Acting Insulin) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Basal Insulin (Long-Acting Insulin) Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Basal Insulin (Long-Acting Insulin) Price by Application (2019-2030) & (US$/Unit)
    Figure 29. North America Basal Insulin (Long-Acting Insulin) Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Basal Insulin (Long-Acting Insulin) Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Basal Insulin (Long-Acting Insulin) Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Basal Insulin (Long-Acting Insulin) Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Basal Insulin (Long-Acting Insulin) Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Basal Insulin (Long-Acting Insulin) Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Basal Insulin (Long-Acting Insulin) Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Basal Insulin (Long-Acting Insulin) Sales Volume (%), (2019-2030)
    Figure 41. United States Basal Insulin (Long-Acting Insulin) Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Basal Insulin (Long-Acting Insulin) Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Basal Insulin (Long-Acting Insulin) Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Basal Insulin (Long-Acting Insulin) Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Basal Insulin (Long-Acting Insulin) Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Basal Insulin (Long-Acting Insulin) Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Basal Insulin (Long-Acting Insulin) Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Basal Insulin (Long-Acting Insulin) Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Basal Insulin (Long-Acting Insulin) Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Basal Insulin (Long-Acting Insulin) Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Basal Insulin (Long-Acting Insulin) Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Basal Insulin (Long-Acting Insulin) Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Basal Insulin (Long-Acting Insulin) Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Basal Insulin (Long-Acting Insulin) Sales Value by Application (%), 2023 VS 2030
    Figure 62. Basal Insulin (Long-Acting Insulin) Industrial Chain
    Figure 63. Basal Insulin (Long-Acting Insulin) Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Description

Long-acting insulins are also called basal or background insulins. The role of basal insulin, also known as background insulin, is to keep blood glucose levels at consistent levels during periods of fasting. When fasting , the body steadily releases glucose into the blood to our cells supplied with energy.

The global market for Basal Insulin (Long-Acting Insulin) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Basal Insulin (Long-Acting Insulin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Basal Insulin (Long-Acting Insulin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Basal Insulin (Long-Acting Insulin) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Basal Insulin (Long-Acting Insulin) include Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico and Wockhardt, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Basal Insulin (Long-Acting Insulin), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Basal Insulin (Long-Acting Insulin) by region & country, by Type, and by Application.

The Basal Insulin (Long-Acting Insulin) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Basal Insulin (Long-Acting Insulin).

Market Segmentation